Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30002277
Basic Information
VIS ID
TVIS30002277
Fusion event
HIV-YY1 integration
Validated
No
Detection method
QiaQuick PCR and Sequencing
Data source
download(RID)
Sample type
Cell line
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2013
PubMed ID
23953889
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr14
Cytoband
q32.2
Reference genome
GRCh37/hg19
Start
100719384/100253047 (Hg38)
End
100719384/100253047 (Hg38)
Orient
+
Location type
Intronic
Target gene
YY1
miRNAs that regulate target gene
hsa-mir-34a-5p
;
hsa-mir-31-5p
;
hsa-mir-93-5p
;
hsa-mir-769-3p
;
hsa-mir-615-3p
;
hsa-mir-484
;
hsa-mir-331-3p
;
hsa-mir-221-3p
;
hsa-mir-7-5p
;
hsa-mir-205-5p
;
hsa-mir-34b-3p
;
hsa-mir-34c-5p
;
hsa-mir-4279
;
hsa-mir-1976
;
hsa-mir-3653-5p
;
hsa-mir-6727-3p
;
hsa-mir-6747-3p
;
hsa-mir-4722-3p
;
hsa-mir-4532
;
hsa-mir-1247-3p
;
hsa-mir-548aw
;
hsa-mir-6790-5p
;
hsa-mir-4658
;
hsa-mir-4758-5p
;
hsa-mir-1238-5p
;
hsa-mir-1468-3p
;
hsa-mir-548x-5p
;
hsa-mir-548g-5p
;
hsa-mir-548f-5p
;
hsa-mir-548aj-5p
;
hsa-mir-1909-5p
;
hsa-mir-1208
;
hsa-mir-6760-3p
;
hsa-mir-4496
;
hsa-mir-651-3p
;
hsa-mir-301b-3p
;
hsa-mir-301a-3p
;
hsa-mir-3666
;
hsa-mir-454-3p
;
hsa-mir-4295
;
hsa-mir-130a-3p
;
hsa-mir-130b-3p
;
hsa-mir-19a-3p
;
hsa-mir-19b-3p
;
hsa-mir-5007-3p
;
hsa-mir-27b-5p
;
hsa-mir-1279
;
hsa-mir-5588-3p
;
hsa-mir-8066
;
hsa-mir-183-5p
;
hsa-mir-892b
;
hsa-mir-193b-3p
;
hsa-mir-193a-3p
;
hsa-mir-491-3p
;
hsa-mir-568
;
hsa-mir-4795-3p
;
hsa-mir-466
;
hsa-mir-4672
;
hsa-mir-4729
;
hsa-mir-3941
;
hsa-mir-6504-3p
;
hsa-mir-586
;
hsa-mir-3976
;
hsa-mir-4643
;
hsa-mir-4789-3p
;
hsa-mir-543
;
hsa-mir-571
;
hsa-mir-219a-1-3p
;
hsa-let-7c-3p
;
hsa-mir-3177-5p
;
hsa-mir-6793-3p
;
hsa-mir-3613-3p
;
hsa-mir-338-5p
;
hsa-mir-548t-5p
;
hsa-mir-548az-5p
;
hsa-mir-374b-3p
;
hsa-mir-5682
;
hsa-mir-585-5p
;
hsa-mir-6507-5p
;
hsa-mir-511-5p
;
hsa-mir-3613-5p
;
hsa-mir-6830-3p
;
hsa-mir-3133
;
hsa-mir-5590-3p
;
hsa-mir-340-5p
;
hsa-mir-142-5p
;
hsa-mir-186-5p
;
hsa-mir-219a-2-3p
;
hsa-mir-4522
;
hsa-mir-6870-3p
;
hsa-mir-138-1-3p
;
hsa-mir-3679-3p
;
hsa-mir-6840-5p
;
hsa-mir-2115-5p
;
hsa-mir-3155b
;
hsa-mir-3155a
;
hsa-mir-548o-3p
;
hsa-mir-5582-3p
;
hsa-mir-1323
;
hsa-mir-1273h-5p
;
hsa-mir-1299
;
hsa-mir-149-3p
;
hsa-mir-204-3p
;
hsa-mir-2467-5p
;
hsa-mir-30b-3p
;
hsa-mir-3192-5p
;
hsa-mir-3689a-3p
;
hsa-mir-3689b-3p
;
hsa-mir-3689c
;
hsa-mir-378a-3p
;
hsa-mir-378b
;
hsa-mir-378c
;
hsa-mir-378d
;
hsa-mir-378e
;
hsa-mir-378f
;
hsa-mir-378h
;
hsa-mir-378i
;
hsa-mir-422a
;
hsa-mir-4314
;
hsa-mir-4638-3p
;
hsa-mir-4646-5p
;
hsa-mir-4728-5p
;
hsa-mir-4778-5p
;
hsa-mir-4782-5p
;
hsa-mir-516b-5p
;
hsa-mir-5706
;
hsa-mir-619-5p
;
hsa-mir-630
;
hsa-mir-6506-5p
;
hsa-mir-6779-5p
;
hsa-mir-6780a-5p
;
hsa-mir-6785-5p
;
hsa-mir-6799-5p
;
hsa-mir-6883-5p
;
hsa-mir-7106-5p
;
hsa-mir-455-3p
;
hsa-mir-5689
;
hsa-mir-5696
;
hsa-mir-6516-5p
;
hsa-mir-1281
;
hsa-mir-129-5p
;
hsa-mir-1304-3p
;
hsa-mir-139-3p
;
hsa-mir-2276-3p
;
hsa-mir-30c-1-3p
;
hsa-mir-30c-2-3p
;
hsa-mir-3122
;
hsa-mir-3913-5p
;
hsa-mir-4294
;
hsa-mir-431-5p
;
hsa-mir-4485-5p
;
hsa-mir-450a-1-3p
;
hsa-mir-6513-5p
;
hsa-mir-6731-5p
;
hsa-mir-6778-3p
;
hsa-mir-6788-5p
;
hsa-mir-6878-5p
;
hsa-mir-6890-3p
;
hsa-mir-8085
;
hsa-mir-887-5p
;
hsa-mir-924
Nearest miRNA
hsa-mir-1260a/Upstream/143294; hsa-mir-1185-1/Downstream/24310;
Nearest TSS
ENST00000550708/Upstream/13288;
ENST00000554579/Downstream/22682;
Nearest CpG islands
None/Target,
chr14-CpG: 35/Upstream/12317
,
chr14-CpG: 72/Downstream/32288
Nearest cancer related gene
YY1
(OG, No orient, 0)
Upstream sequence
ctggaggatcacttgagctagggaggttgaggctgcattgagcagtgatagtgccactgcactccagcctggacaacagagtgagaccctgtctcaaagg
Downstream sequence
aaaagaaagaaagaaaCCCATAGAAACTTCTAATGGGGTTAACTATGTCCTGTGAAACAATAAAAGATCCTGTCCTCAAGGGAAACTCCAGCAGGGAATA
Reference
Sherrill-Mix, S., et al. HIV latency and integration site placement in five cell-based models.2013, Retrovirology 10: 90.
Sample Information
×
Sample name
Active CD4+
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate